Prenetics sells its stake in ACT Genomics and may explore Bitcoin financial strategies.

TokenomicsTrapper · 2025-06-18T12:46:32+00:00

Nasdaq company Prenetics announced the transfer of its ownership in ACT Genomics to Delta Electronics for approximately $71.78 million. After the divestment, it is expected to have cash reserves of $86 million, maintaining a zero-debt balance sheet, and can explore digital asset and Bitcoin financial strategies.

TokenomicsTrapper

2025-06-18 12:46:32

Abstract generation in progress

NASDAQ-listed Prenetics announced that it has entered into a definitive agreement to transfer its ownership of ACT Genomics Holdings Company Limited to Delta Electronics Co., Ltd. for approximately $71.78 million. The divestiture of ACT Genomics significantly strengthens Prenetics’ financial foundation, with projected cash reserves of approximately $86 million and projected cash and short-term assets of $117 million. The company maintains a debt-free balance sheet with zero debt, allowing it to explore other financial management options, including digital asset adoption and Bitcoin financial strategies.

ACT5,25%

BTC0,1%

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

20 Likes